[Skip to Navigation]
Comment & Response
September 2017

Human Papillomavirus Vaccination and Keratinocyte Carcinomas

Author Affiliations
  • 1Department of Dermatology, University of Colorado School of Medicine, Aurora, Colorado
JAMA Dermatol. 2017;153(9):946-947. doi:10.1001/jamadermatol.2017.1485

To the Editor I enjoyed reading the article by Nichols et al1 on using the human papillomavirus (HPV) vaccine for the prevention of keratinocyte carcinomas (KCs). They found that 2 patients given the HPV vaccine had a large decrease in both squamous cell carcinomas (SCCs) (about 65%) and basal cell carcinomas (BCCs) (100%). However, further study details are needed to clarify whether the HPV vaccine is indeed a magic bullet or if the results are due to selection bias.

Add or change institution